Deep Dive Randomized Control Trial

This study has been completed.
Sponsor:
Collaborators:
Health Net California
Highmark Blue Cross Blue Shield
Information provided by:
Health Dialog
ClinicalTrials.gov Identifier:
NCT00793260
First received: November 17, 2008
Last updated: November 18, 2008
Last verified: November 2008
  Purpose

Compare two care management support program models on medical costs and utilization.


Condition Intervention
Chronic Disease
Arthritis
Uterine Diseases
Spinal Diseases
Preventive Health Services
Behavioral: Enhanced Support
Behavioral: Usual-Support

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Official Title: Deep Dive Randomized Control Trial

Resource links provided by NLM:


Further study details as provided by Health Dialog:

Primary Outcome Measures:
  • The primary outcome measure was total medical costs (capped at $200,000 per individual per year) and pharmacy costs. [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Secondary measures included utilization of selected services. [ Designated as safety issue: No ]

Enrollment: 174120
Study Start Date: July 2006
Study Completion Date: May 2008
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Usual Support Group
Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification). The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs. These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.
Behavioral: Usual-Support
Predictive models in the Usual-Support Group were aimed at identifying individuals through medical claims and administrative data (such as hospitalization notification). The output of the predictive models is a rank-ordered, or stratified, list of individuals who have support needs. These lists were then used to generate outbound mail, interactive voice response (IVR) calls or calls by health coaches.
Experimental: Enhanced Support Group
The Enhanced-Support Group intervention used more sophisticated predictive models, more extensive outreach to engage individuals, and provided tighter feedback loops to inform the care support process.
Behavioral: Enhanced Support

The Enhanced-Support Group program used lower risk thresholds for targeted outreach of individuals with chronic illness and for those likely to face discrete surgical interventions. Individuals at high financial risk but without one of the five chronic conditions were included in the Enhanced-Support Group.

The Enhanced-Support Group received up to five initial reach attempts while the Usual-Support Group received up to three attempts.

The Enhanced-Support Group used a 'tight loop' management structure including detailed, timely coach level feedback reports on efficiency and effectiveness.


  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All employees, dependents and retirees in one of seven large employer groups, including a state university system, a state employee group, two manufacturing companies, a natural resource extraction company, a public educational service agency, and a nonprofit multiple employer association for independent colleges were eligible for inclusion.

Exclusion Criteria:

  • no financial information was available from their facility and professional claims;
  • they were in an employer sub-group ineligible for care support services;
  • they asked not be to contacted or were deceased;
  • gender information was missing from their eligibility files;
  • their claims data from the year prior to the start of the study indicated diagnoses of HIV, AIDS, end-stage renal disease (ESRD), organ transplants, or necrotizing fasciitis (intended to improve the likelihood of a balanced distribution of costs and conditions); OR
  • they were in an employer sub-group with less than four months of enrollment prior to the study start date (resulting in too little information for stratification).
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00793260

Locations
United States, Maine
Health Dialog Analytic Solutions, Inc
Portland, Maine, United States, 04101
Sponsors and Collaborators
Health Dialog
Health Net California
Highmark Blue Cross Blue Shield
Investigators
Principal Investigator: David E Wennberg, MD, MPH Health Dialog
  More Information

No publications provided by Health Dialog

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: David E. Wennberg, MD, MPH / Chief Science & Products Officer, Health Dialog Analytic Solutions, Inc
ClinicalTrials.gov Identifier: NCT00793260     History of Changes
Other Study ID Numbers: DeepDive
Study First Received: November 17, 2008
Last Updated: November 18, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Chronic Disease
Spinal Diseases
Uterine Diseases
Disease Attributes
Pathologic Processes
Bone Diseases
Musculoskeletal Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on September 30, 2014